🇺🇸 FDA
Patent

US 8846040

Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K2039/505A61K2039/542

Quick answer

US patent 8846040 (Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K2039/542, A61K2039/545, A61K38/00